Cardiovascular Systems, Inc. (CSII)
Market Cap | 572.53M |
Revenue (ttm) | 237.53M |
Net Income (ttm) | -38.95M |
Shares Out | 41.88M |
EPS (ttm) | -0.99 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 227,086 |
Open | 14.66 |
Previous Close | 14.72 |
Day's Range | 13.64 - 14.70 |
52-Week Range | 12.26 - 23.47 |
Beta | 0.84 |
Analysts | Buy |
Price Target | 20.40 (+49.12%) |
Earnings Date | Feb 9, 2023 |
About CSII
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Co... [Read more]
Financial Performance
In 2022, CSII's revenue was $236.22 million, a decrease of -8.79% compared to the previous year's $258.97 million. Losses were -$36.93 million, 175.2% more than in 2021.
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for CSII stock is "Buy." The 12-month stock price forecast is $20.4, which is an increase of 49.12% from the latest price.
News

Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays
Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.

Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (NASDAQ: CSII) plans to announce its operating results for the quarter ended December 31, 2022 before the market opens on Thursday, Feb...

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.'s Thrombectomy System
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patien...

Cardiovascular Systems (CSII) Q1 Earnings Miss, Revenues Top
The launch of the Scoreflex scoring balloon receives a positive response and generates over $1.7 million in sales during the first quarter for Cardiovascular Systems (CSII).

Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
ST. PAUL, Minn.

Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st...

Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
ST. PAUL, Minn.

Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Cardiovascular Systems (CSII) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
ST. PAUL, Minn.

Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
ST. PAUL, Minn.

Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?

Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark
According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.

Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022

Cardiovascular Systems (CSII) Up 0.9% Since Last Earnings Report: Can It Continue?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?

Cardiovascular Systems' (CSII) Q3 Earnings Top Estimates
Cardiovascular Systems' (CSII) third-quarter revenues declined year over year due to lower Coronary and peripheral revenues.

Cardiovascular Systems (CSII) Reports Q3 Loss, Lags Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 10.71% and 2%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients w...

Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Cardiovascular Systems (CSII) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Medical Product Stocks Poised to Beat This Earnings Season
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.

Here's Why You Should Hold on to Cardiovascular Systems (CSII)
Investors are optimistic about Cardiovascular Systems' (CSII) robust international growth and upcoming launches.

Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. TO HOST EARNINGS CONFERENCE CALL ON MAY 4, 2022

Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. TO PARTICIPATE AT TWO UPCOMING HEALTHCARE CONFERENCES

Cardiovascular Systems, Inc. Announces First In-Human Experience With Company's Propel™ Percutaneous Ventricular Assist Device
ST. PAUL, Minn.--(BUSINESS WIRE)--CARDIOVASCULAR SYSTEMS, INC. ANNOUNCES FIRST IN-HUMAN EXPERIENCE WITH COMPANY'S PROPEL™ PERCUTANEOUS VENTRICULAR ASSIST DEVICE